ViziLite TBlue

Better screening saves lives.®

vizilite-and-tblueViziLite® TBlue® is used to help oral healthcare professionals identify, evaluate, monitor and mark abnormal oral cell lesions suspicious for pathology including precancerous and cancerous cells that may be difficult to see during a regular visual exam.

ViziLite TBlue Advantage:

  • Quick and easy-to use system that incorporates seamlessly into your standard visual examination – procedure only takes 2 minutes to complete
  • Small device size enables easier access to see and focus light inside the oral cavity
  • Disposable technology eliminates cross-contamination and improves infection control
  • Patented and clinically proven technology that has been helping healthcare professionals for more than a decade
  • A clinical study has shown that the use of ViziLite TBlue after a conventional visual examination resulted in1:
    • NO FALSE NEGATIVE OUTCOMES, meaning in this clinical study ViziLite TBlue identified every lesion that had precancerous or cancerous cells
    • SIGNIFICANTLY REDUCED the number of false positive lesions identified during standard visual examinations – limiting the number of biopsies that may have normally been performed

Below is an image of Squamous cell carcinoma – identified and stained with ViziLite TBlue

squamous_normal
What you see under normal light		 squamous_vizilite
What you see using ViziLite Plus

For more information on ViziLite TBlue, download the package insert